In gliomas, our group recently reported that WNK2 downregulation results in increased cell proliferation, tumor growth, cell migration and invasion [16], corroborating other's theory that WNK2 functions as a tumor-suppressor gene [15, 19]. The gene discussed is WNK2; the disease is neoplasm.